Liquid Biopsy For Personalised Monitoring Of Melanoma Patients
Funder
National Health and Medical Research Council
Funding Amount
$820,888.00
Summary
Despite the success of recent melanoma treatments, therapies are effective long term in only a proportion of patients. Here we will progress preliminary findings in collaboration with biotechnology and pathology companies to develop highly effective companion biomarkers that will aid treatment decisions throughout disease course. Our team will spearhead translation of these markers into the clinic for routine monitoring of melanoma patients.
Early diagnosis of melanoma remains extremely challenging. Currently there are no validated blood-based biomarkers for early diagnosis. Therefore, a reliable screening test is an unmet medical need. Autoantibodies are emerging as promising biomarkers for early cancer detection. In a proof of principle experiment we identified five autoantibodies that provide 95% sensitivity / specificity. Now we will confirm and validate our findings and develop a clinical test for melanoma diagnosis.
Discovery Early Career Researcher Award - Grant ID: DE120101331
Funder
Australian Research Council
Funding Amount
$375,000.00
Summary
Fundamental electromagnetic modelling of light-biological tissue interactions: a platform for future medical microscopy. Methods for modelling the fundamental electromagnetic interaction of light with biological tissue will be developed. This will allow a range of biomedical optical images to be properly interpreted ultimately leading to the holy grail of quick and minimally invasive methods for detecting cancer.